Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Free Cash Flow of -$109.9 million in Q4 2024, down 256.62% quarter-over-quarter from $70.2 million in Q3 2024, and down 189.67% on a YoY basis from $122.5 million in Q1 2024.
Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Free Cash Flow history runs 6 years deep, the most recent figure standing at -$109.9 million for Q4 2024.
- In Q4 2024, Free Cash Flow fell 189.67% year-over-year to -$109.9 million; the TTM figure through Sep 2025 stood at -$109.9 million (down 204.28% YoY), while the FY2025 annual figure was $134.9 million, up 89.56% from the prior year.
- Free Cash Flow was -$109.9 million for Q4 2024 at Curaleaf Holdings, down from $70.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $43.8 billion in Q1 2024 to a low of -$43.7 billion in Q2 2024.
- Historically, Free Cash Flow has averaged -$14.0 million across 5 years, with a median of -$831812.5 in 2020.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow jumped 180648.47% in 2021, then tumbled 11641.34% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$177.3 million in 2020, then soared by 113.4% to $23.8 million in 2021, then sank by 1057.64% to -$227.5 million in 2022, then soared by 83.33% to -$37.9 million in 2023, then sank by 189.67% to -$109.9 million in 2024.
- The last three Free Cash Flow figures came in at -$109.9 million (Q4 2024), $70.2 million (Q3 2024), and -$43.7 billion (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -109.89 Mn |
| Dec 31, 2024 | -109.89 Mn |
| Sep 30, 2024 | 70.16 Mn |
| Sep 30, 2024 | 70.16 Mn |
| Jun 30, 2024 | -43.70 Bn |
| Jun 30, 2024 | -43.70 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Dec 31, 2023 | -37.94 Mn |
| Dec 31, 2023 | -37.94 Mn |
| Sep 30, 2023 | 62.18 Mn |
| Sep 30, 2023 | 62.18 Mn |
| Jun 30, 2023 | -7.88 Bn |
| Jun 30, 2023 | -7.88 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Dec 31, 2022 | -227.53 Mn |
| Dec 31, 2022 | -227.53 Mn |
| Sep 30, 2022 | 43.98 Mn |
| Sep 30, 2022 | 43.98 Mn |